A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 5913-5919

  Charo, Jehad ^a,b,d   Ciupitu, Anne Marie T ^a,b   De Préville, Alain Le Chevalier ^a   Trivedi, Pankaj ^b   Klein, George ^b   Hinkula, Jorma ^c   Kiessling, Rolf ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID DNA; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER PREVENTION; CELLULAR IMMUNITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE GUN; GENE TARGETING; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE;

ADENOCARCINOMA; ANIMALS; CANCER VACCINES; CROSS REACTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENES, VIRAL; IMMUNOLOGIC MEMORY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PLASMIDS; SPLEEN; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA;

EID: 0033485422     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Epstein, M. A., and D. H. Crawford. 1998. Gammaherpesviruses: Epstein-Barr virus. In Microbiology and Microbial Infection, Vol. 1. L. Collier, A. Balows, and M. Sussman, eds. Arnold, London, p. 351.
2. Rickinson, A. B., and E. D. Kieff. 1996. Epstein-Barr virus. In Fields Virology. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2397.
3. Kieff, E. D. 1996. Epstein-Barr virus and its replication. In Fields Virology. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2343.
4. Magrath, I. T., and J. G. Judde. 1997. Epstein-Barr virus and neoplasia. In Encyclobedia of Cancer, Vol. I. J. R. Bertino, ed. Academic Press, San Diego, p. 642.
5. Klein, G. 1994. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791.
6. Klein, G. 1994. Viruses and cancer. In Viruses and Cancer. A. Minson, J. Neill, and M. McCrae, eds. Society for General Microbiology, Cambridge, p. 1.
7. Spring, S. B., G. Hascall, and J. Gruber. 1996. Issues related to development of Epstein-Barr virus vaccines. J. Natl. Cancer Inst. 88:1436.
8. Pardoll, D. M. 1998. Cancer vaccines. Nat. Med. 4:525.
9. Banerjee, S., E. Livanos, and J. M. Vos. 1995. Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus. Nat. Med. 1:1303.
10. Evans, T. J., L. Brooks, and P. J. Farrell. 1997. A strategy for specific targeting of therapeutic agents to tumor cells of virus-associated cancers. Gene Ther. 4:264.
11. Franken, M., A. Estabrooks, L. Cavacini, B. Sherburne, F. Wang, and D. T. Scadden. 1996. Epstein-Barr virus-driven gene therapy for EBV-related lymphomas. Nat. Med. 2:1379.
12. Gutierrez, M. I., J. G. Judde, I. T. Magrath, and K. G. Bhatia. 1996. Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia. Cancer Res. 56:969.
13. Huang, S., D. Stupack, P. Mathias, Y. Wang, and G. Nemerow. 1997. Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes. Proc. Natl. Acad. Sci. USA 94:8156.
14. Judde, J. G., G. Spangler, J. Magrath, and K. Bhatia. 1996. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia. Hum. Gene Ther. 7:647.
15. Rogers, R. P., J. Q. Ge, E. Holley-Guthrie, D. K. Hoganson, K. E. Comstock, J. C. Olsen, and S. Kenney. 1996. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase. Hum. Gene Ther. 7:2235.
16. Gu, S. Y., T. M. Huang, L. Ruan, Y. H. Miao, H. Lu, C. M. Chu, M. Motz, and H. Wolf. 1995. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev. Biol. Stand. 84:171.
17. Hilleman, M. R. 1993. The promise and the reality of viral vaccines against cancer. Ann. NY Acad. Sci. 690:6.
18. Khanna, R., S. R. Burrows, M. G. Kurilla, C. A. Jacob, I.S. Misko, T. B. Sculley, E. Kieff, and D. J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169.
19. Morgan, A. J. 1995. Development of Epstein-Barr Virus Vaccines. R. G. Landes Company, Austin.
20. Moss, D. J., S. R. Burrows, A. Suhrbier, and R. Khanna. 1994. Potential antigenic targets on Epstein-Barr virus-associated tumors and the host response. Ciba Found. Symp. 187:4.
21. Moss, D. J., C. Schmidt, S. Elliott, A. Suhrbier, S. Burrows, and R. Khanna. 1996. Strategies involved in developing an effective vaccine for EBV-associated diseases. Adv. Cancer Res. 69:213.
22. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405.
23. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617.
24. Eisenbraun, M. D., D. H. Fuller, and J. R. Haynes. 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:791.
25. Ertl, H. C., and Z. Q. Xiang. 1996. Genetic immunization. Viral Immunol. 9:1.
26. Davis, H. L., B. A. Demeneix, B. Quantin, J. Coulombe, and R. G. Whalen. 1993. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:733.
27. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90:11478.
28. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465.
29. Yang, N. S., J. Burkholder, B. Roberts, B. Martinell, and D. McCabe. 1990. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87:9568.
30. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156.
31. Tang, D. C., M. De Vit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152.
32. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
33. Kuzumaki, N., I. A. More, A. J. Cochran, and G. Klein. 1980. Thirteen new mammary tumor cell lines from different mouse strains. Eur. J. Cancer 16:1181.
34. Trivedi, P., G. Winberg, and G. Klein. 1997. Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model system. Eur. J. Cancer 33:912.
35. Xiang, Z., and H. C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129.
36. Kim, J. J., N. N. Trivedi, L. K. Nottingham, L. Morrison, A. Tsai, Y. Hu, S. Mahalingam, K. Dang, L. Ahn, N. K. Doyle, et al. 1998. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28: 1089.
37. Xiang, Z. Q., Z. He, Y. Wang, and H. C. Ertl. 1997. The effect of interferon-γ on genetic immunization. Vaccine 15:896.
38. Xiang, Z. Q., S. Pasquini, Z. He, H. Deng, Y. Wang, M. A. Blaszczyk-Thurin, and H. C. Ertl. 1997. Genetic vaccines: a revolution in vaccinology? Springer Semin. Immunopathol. 19:257.
39. Syrengelas, A. D., T. T. Chen, and R. Levy. 1996. DNA immunization induces protective immunity against B-cell lymphoma. Nat. Med. 2:1038.
40. Corr, M. D. J. Lee, D. A. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555.
41. Chattergoon, M. A., T. M. Robinson, J. D. Boyer, and D. B. Weiner. 1998. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J. Immunol. 160:5707.
42. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo Jr. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.
43. Iwasaki, A., C. A. Torres, P. S. Ohashi, H. L. Robinson, and B. H. Barber. 1997. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:11.
44. Boyle, J. S., J. L. Brady, and A. M. Lew. 1998. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408.
45. Barry, M. A., and S. A. Johnston. 1997. Biological features of genetic immunization. Vaccine 15:788.
46. Lukacs, K. V., D. B. Lowrie, R. W. Stokes, and M. J. Colston. 1993. Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors. J. Exp. Med. 178:343.
47. Cheng, T. Y., J. T. Wu, and R. H. Lin. 1998. Induction of tumor-specific T cell response by cognating tumor cells with foreign antigen-primed Th cells. Int. Immunol. 10:1397.
48. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:2278.
49. Robinson, H. L. 1997. Nucleic acid vaccines: an overview. Vaccine 15:785.
50. Liu, M. A. 1998. Vaccine developments. Nat. Med. 4:515.
51. Lucas, K. G., K. E. Pollok, and D. J. Emanuel. 1997. Post-transplant EBV induced lymphoproliferative disorders. Leukemia Lymphoma 25:1.
52. Rooney, C. M., M. A. Roskrow, C. A. Smith, M. K. Brenner, and H. E. Heslop. 1998. Immunotherapy for Epstein-Barr virus-associated cancers. J. Natl. Cancer Inst. Monographs23:89.
53. Bot, A., S. Bot, A. Garcia-Sastre, and C. Bona. 1996. DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. Viral Immunol. 9:207.
54. Klein, G., and E. Klein. 1998. Sinking surveillance's flagship. Nature 395:441.
55. Kieff, E. D. 1998. Current perspectives on the molecular pathogenesis of virus- induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl. Cancer Inst. Monographs 23:7.
56. Henderson, S. A., D. Huen, and M. Rowe. 1994. Epstein-Barr virus transforming proteins. Semin. Virol. 5:391.